Dorota Jurkiewicz

Dorota Jurkiewicz

Auto-generated profile, based on publicly available information

Dorota Jurkiewicz

Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2010 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MLMelissa Leyva‐Vega
Melissa Leyva‐Vega
JGJennifer Gerfen
Jennifer Gerfen
BTBrian D. Thiel
Brian D. Thiel
DJDorota Jurkiewicz
Dorota Jurkiewicz
ERElizabeth B. Rand
Elizabeth B. Rand
NSNancy B. Spinner
Nancy B. Spinner

9 September 2016 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
DJDorota Jurkiewicz
Dorota Jurkiewicz
MKMonika Kugaudo
Monika Kugaudo
ASAgata Skórka
Agata Skórka
RŚRobert Śmigiel
Robert Śmigiel
MSMarta Smyk
Marta Smyk
MKMałgorzata Krajewska-Walasek
Małgorzata Krajewska-Walasek

3 September 2010 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
DPDorota Piekutowska-Abramczuk
Dorota Piekutowska-Abramczuk
RORikke Katrine Jentoft Olsen
Rikke Katrine Jentoft Olsen
JWJolanta Maria Wierzba
Jolanta Maria Wierzba
EPEwa Popowska
Ewa Popowska
DJDorota Jurkiewicz
Dorota Jurkiewicz
EPEwa Pronicka
Ewa Pronicka

20 April 2014 in Journal of Applied Genetics
Verified
Journal Article
Open access
PDF file
DJDorota Jurkiewicz
Dorota Jurkiewicz
DGDorota Gliwicz
Dorota Gliwicz
ECElżbieta Ciara
Elżbieta Ciara
JGJennifer Gerfen
Jennifer Gerfen
MPMagdalena Pelc
Magdalena Pelc
MKMałgorzata Krajewska-Walasek
Małgorzata Krajewska-Walasek
Alagille syndrome (ALGS) is an autosomal dominant disorder characterized by developmental abnormalities in several organs including the liver, heart, eyes, vertebrae, kidneys, and face. The majority (90-94 %) of ALGS cases are caused by mutations in the JAG1 (JAGGED1) gene, and in a small percent of patients (∼1 %) mutations in the NOTCH2 gene have been described. Both genes are involved in the Notch signaling pathway. To date, over 440 different JAG1 gene mutations and ten NOTCH2 mutations have been identified in ALGS patients. The present study was conducted on a group of 35 Polish ALGS patients and revealed JAG1 gene mutations in 26 of them. Twenty-three different mutations were detected including 13 novel point mutations and six large deletions affecting the JAG1 gene. Review of all mutations identified to date in individuals from Poland allowed us to propose an effective diagnostic strategy based on the mutations identified in the reported patients of Polish descent. However, the distribution of mutations seen in this cohort was not substantively different than the mutation distribution in other reported populations.

1 November 2006 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
ECElżbieta Ciara
Elżbieta Ciara
EPE. Popowska
E. Popowska
DPDorota Piekutowska-Abramczuk
Dorota Piekutowska-Abramczuk
DJD. Jurkiewicz
D. Jurkiewicz
MBM. Borucka-Mankiewicz
M. Borucka-Mankiewicz
MKMałgorzata Krajewska-Walasek
Małgorzata Krajewska-Walasek

14 February 2005 in Human Mutation
Verified
Journal Article
Open access
PDF file
DJDorota Jurkiewicz
Dorota Jurkiewicz
EPEwa Popowska
Ewa Popowska
CGChristiane Gläser
Christiane Gläser
IHIngo Hansmann
Ingo Hansmann
MKMałgorzata Krajewska-Walasek
Małgorzata Krajewska-Walasek
Alagille syndrome (AGS) is an autosomal dominant disorder with developmental abnormalities of the liver, heart, eyes, vertebrae, and face. Mutations in the JAG1 (Jagged 1) gene, coding a ligand in the evolutionarily conserved Notch signaling pathway, are responsible for AGS. Here we present sixteen different JAG1 gene mutations, among them twelve novel, not described previously. Seven frameshift: c. 172_178del7 (p.Ala58fs), c.509delT (p.Leu170fs), c.1197delG (p.Val399fs), c.1485_1486delCT (p.Pro495fs), c.1809_1810insTGGG (p.Lys604fs), c.2122_2125delCAGT (p.Gln708fs), c.2753delT (p.Ile918fs); five nonsense: c.383G>A (p.Trp128X), c.496C>T (p.Glu166X), c.841C>T (p.Gln281X), c.1207C>T (p.Gln403X), c.1603C>T (p.Gln535X); two splice site: c.388‐1G>C, c.3048+1_3048+2insG and two missense mutations: c.359T>A (p.Ile120Asn), c.560G>A (p.Cys187Tyr) were found. Forty percent of the changes were identified in exons 2 and 4, the remaining mutations are distributed along the entire coding sequence of the gene. Seventy‐five percent of the mutations lead to creation of premature termination codons. Family studies revealed that the specific mutations were inherited in 3 out of 11 investigated cases. No correlation between genotype and phenotype was observed.